EV/EBITDA:
-20.61+0.64(+3.01%)Summary
- As of today, TRVI EV/EBITDA is -20.61, with a rise of +0.64 (+3.01%) during the most recent trading session on October 17, 2025.
- Over the past year, TRVI EV/EBITDA has dropped by -17.05 (-478.93%).
- TRVI EV/EBITDA is now -2708.86% below its all-time high of 0.79.
Performance
TRVI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TRVI EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +3.0% | -3.0% | -2.5% |
| 1M1 Month | -37.8% | +37.7% | +29.8% |
| 3M3 Months | -68.1% | +68.0% | +51.5% |
| 6M6 Months | -108.4% | +110.0% | +70.7% |
| YTDYTD | -279.6% | +279.4% | +151.5% |
| 1Y1 Year | -478.9% | +518.9% | +232.1% |
| 5Y5 Years | -2383.1% | +4148.8% | +196.8% |
TRVI EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -14.96 | -37.8% | -21.25 | +3.0% |
| 3M | 3-Month | -12.21 | -68.8% | -21.25 | +3.0% |
| 6M | 6-Month | -9.01 | -128.8% | -21.25 | +3.0% |
| 1Y | 1-Year | -2.64 | -680.7% | -21.25 | +3.0% |
| 3Y | 3-Year | 0.62 | -3424.2% | -21.25 | +3.0% |
| 5Y | 5-Year | 0.79 | -2708.9% | -21.25 | +3.0% |
| All-Time | All-Time | 0.79 | -2708.9% | -21.25 | +3.0% |
TRVI EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -20.61(-279.6%) |
| 2024 | -5.43(-1772.4%) |
| 2023 | -0.29(-93.3%) |
| Date | Value |
|---|---|
| 2022 | -0.15(-1400.0%) |
| 2021 | -0.01(+97.7%) |
| 2020 | -0.44 |
FAQ
- What is Trevi Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Trevi Therapeutics, Inc.?
- What is TRVI EV/EBITDA year-to-date change?
- What is Trevi Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Trevi Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of TRVI is -20.61
What is the all-time high EV/EBITDA for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high EV/EBITDA is 0.79
What is TRVI EV/EBITDA year-to-date change?
Trevi Therapeutics, Inc. EV/EBITDA has changed by -15.18 (-279.56%) since the beginning of the year
What is Trevi Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, TRVI EV/EBITDA has changed by -17.05 (-478.93%)